Specialist Veterinary Cardiology Consultancy Ltd 07233635 false 2024-05-01 2025-04-30 2025-04-30 The principal activity of the company is veterinary cardiology consultancy. Digita Accounts Production Advanced 6.30.9574.0 true 07233635 2024-05-01 2025-04-30 07233635 2025-04-30 07233635 core:CurrentFinancialInstruments 2025-04-30 07233635 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 07233635 core:FurnitureFittings 2025-04-30 07233635 core:LandBuildings core:LongLeaseholdAssets 2025-04-30 07233635 core:MotorVehicles 2025-04-30 07233635 core:OfficeEquipment 2025-04-30 07233635 core:PlantMachinery 2025-04-30 07233635 bus:SmallEntities 2024-05-01 2025-04-30 07233635 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 07233635 bus:FilletedAccounts 2024-05-01 2025-04-30 07233635 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 07233635 bus:RegisteredOffice 2024-05-01 2025-04-30 07233635 bus:Director2 2024-05-01 2025-04-30 07233635 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 07233635 core:FurnitureFittings 2024-05-01 2025-04-30 07233635 core:LandBuildings core:LongLeaseholdAssets 2024-05-01 2025-04-30 07233635 core:LeaseholdImprovements 2024-05-01 2025-04-30 07233635 core:MotorVehicles 2024-05-01 2025-04-30 07233635 core:OfficeEquipment 2024-05-01 2025-04-30 07233635 core:PlantMachinery 2024-05-01 2025-04-30 07233635 core:VehiclesPlantMachinery 2024-05-01 2025-04-30 07233635 countries:EnglandWales 2024-05-01 2025-04-30 07233635 2024-04-30 07233635 core:FurnitureFittings 2024-04-30 07233635 core:LandBuildings core:LongLeaseholdAssets 2024-04-30 07233635 core:MotorVehicles 2024-04-30 07233635 core:OfficeEquipment 2024-04-30 07233635 core:PlantMachinery 2024-04-30 07233635 2023-05-01 2024-04-30 07233635 2024-04-30 07233635 core:CurrentFinancialInstruments 2024-04-30 07233635 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 07233635 core:FurnitureFittings 2024-04-30 07233635 core:LandBuildings core:LongLeaseholdAssets 2024-04-30 07233635 core:MotorVehicles 2024-04-30 07233635 core:OfficeEquipment 2024-04-30 07233635 core:PlantMachinery 2024-04-30 iso4217:GBP xbrli:pure

Registration number: 07233635

Specialist Veterinary Cardiology Consultancy Ltd

Unaudited Filleted Financial Statements

for the Year Ended 30 April 2025

 

Specialist Veterinary Cardiology Consultancy Ltd

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

3 to 7

 

Specialist Veterinary Cardiology Consultancy Ltd

(Registration number: 07233635)
Balance Sheet as at 30 April 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

5

98,637

91,452

Current assets

 

Debtors

6

142,672

127,792

Cash at bank and in hand

 

431,254

413,622

 

573,926

541,414

Creditors: Amounts falling due within one year

7

(75,675)

(92,301)

Net current assets

 

498,251

449,113

Total assets less current liabilities

 

596,888

540,565

Provisions for liabilities

(15,990)

(22,180)

Net assets

 

580,898

518,385

Capital and reserves

 

Called up share capital

100

100

Retained earnings

580,798

518,285

Shareholders' funds

 

580,898

518,385

 

Specialist Veterinary Cardiology Consultancy Ltd

(Registration number: 07233635)
Balance Sheet as at 30 April 2025

For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 3 October 2025 and signed on its behalf by:
 

.........................................
H Ferasin
Director

 

Specialist Veterinary Cardiology Consultancy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of veterinary cardiology services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax payable and deferred tax.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

Specialist Veterinary Cardiology Consultancy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office Equipment

25% Straight line

Plant and Machinery

25% Straight line

Fixtures and Fittings

25% Straight line

Motor Vehicles

20% Straight line

Improvements to Property

25% Straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for veterinary cardiology services performed in the ordinary course of business.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Specialist Veterinary Cardiology Consultancy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

3

Taxation

2025

2024

£

£

Corporation tax

(55,906)

40,709

Deferred tax

(6,188)

645

(62,094)

41,354

4

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 8 (2024 - 6).

 

Specialist Veterinary Cardiology Consultancy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

5

Tangible assets

Improvements to property
£

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Motor vehicles
 £

Total
£

Cost or valuation

At 1 May 2024

7,792

47,903

29,556

22,905

103,437

211,593

Additions

42,354

-

-

2,506

-

44,860

Disposals

-

(306)

-

-

-

(306)

At 30 April 2025

50,146

47,597

29,556

25,411

103,437

256,147

Depreciation

At 1 May 2024

5,062

32,326

29,556

14,886

38,311

120,141

Charge for the year

3,169

10,408

-

3,334

20,687

37,598

Eliminated on disposal

-

(229)

-

-

-

(229)

At 30 April 2025

8,231

42,505

29,556

18,220

58,998

157,510

Carrying amount

At 30 April 2025

41,915

5,092

-

7,191

44,439

98,637

At 30 April 2024

2,730

15,577

-

8,019

65,126

91,452

 

Specialist Veterinary Cardiology Consultancy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2025

6

Debtors

Current

2025
£

2024
£

Trade debtors

61,945

118,724

Prepayments

18,307

9,068

Other debtors

62,420

-

 

142,672

127,792

7

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Trade creditors

166

-

Taxation and social security

62,972

81,750

Other creditors

12,537

10,551

75,675

92,301